Home
Search
Study Topics
Glossary
|
|
|
|
|
Tracking Information | |
---|---|
First Received Date † | January 6, 2009 |
Last Updated Date | January 6, 2009 |
Start Date † | August 2008 |
Current Primary Outcome Measures † |
Recurrence of Atrial Fibrillation [ Time Frame: 6 months ] [ Designated as safety issue: No ] |
Original Primary Outcome Measures † | Same as current |
Change History | No Changes Posted |
Current Secondary Outcome Measures † | |
Original Secondary Outcome Measures † | |
Descriptive Information | |
Brief Title † | Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation in Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm |
Official Title † | Atrial Electromechanical Interval in the Prediction of Recurrence of Atrial Fibrillation In Patients Undergoing Successful Electrical Cardioversion to Sinus Rhythm |
Brief Summary | Atrial electromechanical interval will add incremental value in the prediction of recurrence of atrial fibrillation among patients who underwent successful direct current cardioversion for atrial fibrillation. |
Detailed Description | |
Study Phase | |
Study Type † | Observational |
Study Design † | Cohort, Prospective |
Condition † | Atrial Fibrillation |
Intervention † | |
Study Arms / Comparison Groups | |
Publications * | |
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|
Recruitment Information | |
Recruitment Status † | Recruiting |
Estimated Enrollment † | 130 |
Completion Date | |
Estimated Primary Completion Date | December 2010 (final data collection date for primary outcome measure) |
Eligibility Criteria † | Inclusion Criteria:
Exclusion Criteria:
|
Gender | Both |
Ages | 19 Years and older |
Accepts Healthy Volunteers | No |
Contacts †† | |
Location Countries † | United States |
Expanded Access Status | |
Administrative Information | |
NCT ID † | NCT00818012 |
Responsible Party | Jason Go, MD, Creighton University |
Secondary IDs †† | |
Study Sponsor † | Creighton University |
Collaborators †† | |
Investigators † | |
Information Provided By | Creighton University |
Verification Date | January 2009 |
† Required WHO trial registration data element. †† WHO trial registration data element that is required only if it exists. |